Group 2 suffered more often from comorbidities, such as arterial hypertension, diabetes mellitus and coronary artery disease; however, the difference between the two groups did not reach statistical significance.
← all excerpts
Low DLCO Can Provide Insights into Treatment Response in PAH Patients Irrespective of the Reason for Its Decrease.
1
—
—